Radiat Oncol J.  2017 Sep;35(3):257-267. 10.3857/roj.2017.00290.

Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation

Affiliations
  • 1Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea. YHI0225@yuhs.ac
  • 2Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • 3Division of Pediatric Hemato-oncology, Department of Pediatrics, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea.
  • 4Department of Radiation Oncology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.

Abstract

PURPOSE
Pulmonary toxicities, including infectious pneumonia (IP) and idiopathic pneumonia syndrome (IPS), are serious side effects of total body irradiation (TBI) used for myeloablative conditioning. This study aimed to evaluate clinical factors associated with IP and IPS following TBI.
MATERIALS AND METHODS
Fifty-eight patients with hematologic malignancies who underwent TBI before allogeneic hematopoietic stem cell transplantation between 2005 and 2014 were reviewed. Most patients (91%) received 12 Gy in 1.5 Gy fractions twice a day. Pulmonary toxicities were diagnosed based on either radiographic evidence or reduced pulmonary function, and were subdivided into IP and IPS based on the presence or absence of concurrent infection.
RESULTS
Pulmonary toxicities developed in 36 patients (62%); 16 (28%) had IP and 20 (34%) had IPS. IP was significantly associated with increased treatment-related mortality (p = 0.028) and decreased survival (p = 0.039). Multivariate analysis revealed that the risk of developing IPS was significantly higher in patients who received stem cells from a matched unrelated donor than from a matched sibling donor (p = 0.021; hazard ratio [HR] = 12.67; 95% confidence interval [CI], 1.46-110.30). Combining other conditioning agents with cyclophosphamide produced a higher tendency to develop IP (p = 0.064; HR = 6.19; 95% CI, 0.90-42.56).
CONCLUSION
IP and IPS involve different risk factors and distinct pathogeneses that should be considered when planning treatments before and after TBI.

Keyword

Total body irradiation; Infectious pneumonia; Idiopathic pneumonia syndrome; Stem cell transplantation

MeSH Terms

Cyclophosphamide
Hematologic Neoplasms
Hematopoietic Stem Cell Transplantation
Humans
Mortality
Multivariate Analysis
Pneumonia
Risk Factors
Siblings
Stem Cell Transplantation
Stem Cells
Tissue Donors
Unrelated Donors
Whole-Body Irradiation*
Cyclophosphamide
Full Text Links
  • ROJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr